| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/26/2005 | EP1373255B1 Process for the preparation of imidazole compounds |
| 01/26/2005 | EP1320359B1 Thermogelling biodegradable aqueous polymer solution |
| 01/26/2005 | EP1311514B1 Compositions with vascular damaging activity |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1276504B1 Medicines for treating tumoral pathologies containing the ro5-4864 compound and an apoptosis-inducing agent |
| 01/26/2005 | EP1185279B1 Agents for treating malignant diseases using e1a-deficient adenoviruses with yb-1 protein-dependent replication |
| 01/26/2005 | EP1152009B1 Novel nucleosides and oligonucleotide analogues |
| 01/26/2005 | EP1127133B1 Polypeptide mediating cell permeability |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP1017835A4 Methods of using cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy |
| 01/26/2005 | EP0996636B1 The ha-1 antigen |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0975637B1 Amidino-camptothecin derivatives |
| 01/26/2005 | EP0944592B1 Vitamin d3 derivatives |
| 01/26/2005 | EP0934412B1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF |
| 01/26/2005 | EP0886651B1 Persephin and related growth factors |
| 01/26/2005 | EP0725826B1 Improvements relating to cancer therapy |
| 01/26/2005 | CN1571836A Human antibodies specific for interleukin 15 (IL-15) |
| 01/26/2005 | CN1571834A Cell therapy method for the treatment of tumors |
| 01/26/2005 | CN1571796A Melanocortin receptor ligands |
| 01/26/2005 | CN1571793A Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571789A Himbacine analogues as thrombin receptor antagonists |
| 01/26/2005 | CN1571782A Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571680A PACAP compositions and methods for tumor imaging and therapy |
| 01/26/2005 | CN1571679A PEG-conjugates of HGF-NK4 |
| 01/26/2005 | CN1571674A Use of histamine to treat liver disease |
| 01/26/2005 | CN1571673A Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1571666A Freeze-dried pharmaceutical preparation |
| 01/26/2005 | CN1571662A Highly compressible ethylcellulose for tableting |
| 01/26/2005 | CN1571658A Pharmaceutical formulation comprising (R)-bicalutamide |
| 01/26/2005 | CN1570122A Adenovirus vector for idiopathy liver genetherapy and using method |
| 01/26/2005 | CN1570105A Human rapid contraction of skeletal muscle troponin ó± production and activity detection method |
| 01/26/2005 | CN1570091A Recombinant 1 type herpes simplex virus and its preparation method and uses |
| 01/26/2005 | CN1569900A Heavy chain variable region single domain antibody reinforced fusion protein VH-LDP-AE |
| 01/26/2005 | CN1569879A Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use |
| 01/26/2005 | CN1569863A Method for preparing platinum(II) metal complex eptaplatin |
| 01/26/2005 | CN1569862A Anti-tumor platinum (II) complex |
| 01/26/2005 | CN1569833A Indigo derivative and its preparing process and application |
| 01/26/2005 | CN1569793A Pterocarya stenoptera quinone, its preparation and use |
| 01/26/2005 | CN1569235A Thermotherapy for treating malignant solid tumour by promoting dendritic cell vaccine function |
| 01/26/2005 | CN1569234A Method for killing specific tumour cell by recin |
| 01/26/2005 | CN1569215A Manufacturing method of anticancer ganoderam lucidum preparation |
| 01/26/2005 | CN1569214A Method for preparing anticancer ganoderam lucidum spore |
| 01/26/2005 | CN1569197A Chinese medicinal soft capsule and preparing process thereof |
| 01/26/2005 | CN1569196A Rhodiola sacra injection and its preparation |
| 01/26/2005 | CN1569195A Rhodiola sacra soft capsule and its preparation |
| 01/26/2005 | CN1569137A Chinese medicine for treating neoplasm |
| 01/26/2005 | CN1569108A Medicine for treating cancer and preparing process thereof |
| 01/26/2005 | CN1569063A Chinese medicinal herb composition for treating cancer |
| 01/26/2005 | CN1569058A Innovative technique for processing aloe raw material with high stability |
| 01/26/2005 | CN1569054A Dripping pills of 'Xiao Chaihu' |
| 01/26/2005 | CN1569042A Preparing and assaying method of staphylococcus aureus filtrate preparation |
| 01/26/2005 | CN1569041A Pharmaceutical composition capable of resisting cancer and easing pain |
| 01/26/2005 | CN1568994A Targeted freeze dried nanometer powder injection of hydroxycamptothecine bean phospholipid and its preparation and usage |
| 01/26/2005 | CN1568982A Application of infrared photosensitizer in the photodynamics therapy |
| 01/26/2005 | CN1568974A Usage of cytochalasin D in the preparing process of anticancer medicine |
| 01/26/2005 | CN1568966A Usage of baicalin and its derivatives, analogs in the preparation process of tumor resisting medicine |
| 01/26/2005 | CN1568963A Taxusol composition and its preparing process |
| 01/26/2005 | CN1568962A Application of methylmercury compound in the treatment of encephalic malignant tumour as a anticancer new drug |
| 01/26/2005 | CN1568951A Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 01/26/2005 | CN1186445C Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application |
| 01/26/2005 | CN1186352C HAb18G(/CD147) peptide agonist and its prepn and use |
| 01/26/2005 | CN1186346C Thienopyrrolidinones |
| 01/26/2005 | CN1186340C C10 carbonate substituted taxanes as antitumor agents |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186326C Propane-1, 3-dione derivatives |
| 01/26/2005 | CN1186324C Condensed heteroaryl derivatives |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/26/2005 | CN1186093C Compound fungi medicine for restraining tumors and its preparing method |
| 01/26/2005 | CN1186092C Anticancer Chinese medicine powder preparation and its preparation method |
| 01/26/2005 | CN1186060C Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method |
| 01/26/2005 | CN1186027C Cancer-treating Chinese medicine and its preparation method |
| 01/26/2005 | CN1186013C Peroral medicine deliver controlled system providing temporal and spatial control |
| 01/25/2005 | US6846928 Compositions useful as inhibitors of protein kinases |
| 01/25/2005 | US6846925 Colchinol derivatives as angiogenesis inhibitors |
| 01/25/2005 | US6846913 Crude extract from Viscum album coloratum, and proteins and lectins isolated therefrom |
| 01/25/2005 | US6846834 Antiinflammation agents |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846816 Combinations of drugs for the treatment of neoplastic disorders |
| 01/25/2005 | US6846815 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |
| 01/25/2005 | US6846811 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer |
| 01/25/2005 | US6846674 Gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor, of the signal transduction pathway is modified resulting in a modified AP-1 activity and |
| 01/25/2005 | US6846672 Mitogenic oxygenase regulators |
| 01/25/2005 | US6846665 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
| 01/25/2005 | US6846650 Nucleotide sequences coding polypeptide for use in the imaging, diagnosis, treatment classification and prevention of lung cancer |
| 01/25/2005 | US6846649 Recombinant human mannan-binding lectin |
| 01/25/2005 | US6846476 Treatment of B-cell associated diseases |
| 01/25/2005 | CA2435967A1 Reovirus for the treatment of lymphoid malignancies |
| 01/25/2005 | CA2388674C Inhibitors of endo-exonuclease activity for treating cancer |
| 01/25/2005 | CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists |
| 01/25/2005 | CA2179377C Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 01/25/2005 | CA2131683C Stilbene derivatives and pharmaceutical compositions containing them |